Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camelia Protopopescu

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Journal of Cannabis Research|June 11, 2022
Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohortTangui Barré, Fabrice Carrat, Clémence Ramier, et al.
Blood|October 15, 2015
B-cell non-Hodgkin lymphoma linked to Coxiella burnetiiCléa Melenotte, Matthieu Million, Gilles Audoly, et al.
Hepatology (Baltimore, Md.)|August 30, 2019
Elevated Fatty Liver Index as a Risk Factor for All-Cause Mortality in Human Immunodeficiency Virus-Hepatitis C Virus-Coinfected Patients (ANRS CO13 HEPAVIH Cohort Study)Tangui Barré, Camelia Protopopescu, Firouzé Bani-Sadr, et al.
Journal of Clinical Medicine|October 27, 2022
Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort)Tangui Barré, Marc Bourlière, Clémence Ramier, et al.
The International Journal on Drug Policy|January 7, 2024
All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019Maria-Bernarda Requena, Camelia Protopopescu, Ashleigh C Stewart, et al.
Expert Review of Anti-Infective Therapy|February 4, 2021
Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH)Tangui Barré, Teresa Rojas Rojas, Karine Lacombe, et al.
Drug and Alcohol Review|February 1, 2023
A novel community-based therapeutic education program for reducing alcohol-related harms and stigma in people with alcohol use disorders: A quasi-experimental study (ETHER study)Tangui Barré, Clémence Ramier, Saskia Antwerpes, et al.
Medicine|July 21, 2017
Thrombosis and antiphospholipid antibody syndrome during acute Q fever: A cross-sectional studyMatthieu Million, Nathalie Bardin, Simon Bessis, et al.
Antioxidants (Basel, Switzerland)|February 25, 2022
Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort)Tangui Barré, Hélène Fontaine, Stanislas Pol, et al.
Plos One|March 25, 2022
Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in FranceTeresa Rojas Rojas, Isabelle Poizot-Martin, David Rey, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Journal of Cannabis Research|June 11, 2022
Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohortTangui Barré, Fabrice Carrat, Clémence Ramier, et al.
Blood|October 15, 2015
B-cell non-Hodgkin lymphoma linked to Coxiella burnetiiCléa Melenotte, Matthieu Million, Gilles Audoly, et al.
Hepatology (Baltimore, Md.)|August 30, 2019
Elevated Fatty Liver Index as a Risk Factor for All-Cause Mortality in Human Immunodeficiency Virus-Hepatitis C Virus-Coinfected Patients (ANRS CO13 HEPAVIH Cohort Study)Tangui Barré, Camelia Protopopescu, Firouzé Bani-Sadr, et al.
Journal of Clinical Medicine|October 27, 2022
Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort)Tangui Barré, Marc Bourlière, Clémence Ramier, et al.
The International Journal on Drug Policy|January 7, 2024
All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019Maria-Bernarda Requena, Camelia Protopopescu, Ashleigh C Stewart, et al.
Expert Review of Anti-Infective Therapy|February 4, 2021
Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH)Tangui Barré, Teresa Rojas Rojas, Karine Lacombe, et al.
Drug and Alcohol Review|February 1, 2023
A novel community-based therapeutic education program for reducing alcohol-related harms and stigma in people with alcohol use disorders: A quasi-experimental study (ETHER study)Tangui Barré, Clémence Ramier, Saskia Antwerpes, et al.
Medicine|July 21, 2017
Thrombosis and antiphospholipid antibody syndrome during acute Q fever: A cross-sectional studyMatthieu Million, Nathalie Bardin, Simon Bessis, et al.
Antioxidants (Basel, Switzerland)|February 25, 2022
Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort)Tangui Barré, Hélène Fontaine, Stanislas Pol, et al.
Plos One|March 25, 2022
Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in FranceTeresa Rojas Rojas, Isabelle Poizot-Martin, David Rey, et al.
Pageof 9